DHRS9 Protein, Human (His)

DHRS9 Protein, a 3-alpha-hydroxysteroid dehydrogenase, converts 3-alpha-tetrahydroprogesterone to dihydroxyprogesterone and 3-alpha-androstanediol to dihydroxyprogesterone, supported by studies. Additionally, DHRS9 significantly contributes to retinoic acid biosynthesis from retinaldehyde, utilizing both NADH and NADPH as coenzymes in its reactions. DHRS9 Protein, Human (His) is the recombinant human-derived DHRS9 protein, expressed by E. coli, with N-His labeled tag. The total length of DHRS9 Protein, Human (His) is 302 a.a., with molecular weight of ~34 kDa.

The DHRS9 protein is a 3-alpha-hydroxysteroid dehydrogenase that performs the conversion of 3-alpha-tetrahydroprogesterone (allopregnanolone) to dihydroxyprogesterone and 3-alpha-androstanediol to dihydroxyprogesterone. This enzymatic activity has been supported by studies. Furthermore, DHRS9 also plays a significant role in the biosynthesis of retinoic acid from retinaldehyde, as evidenced by research. Notably, this protein has the ability to utilize both NADH and NADPH as coenzymes in its enzymatic reactions.

Human

E. coli

N-His

Q9BPW9 (R18-V319)

10170  [NCBI]

Approximately 34 kDa

Greater than 90% as determined by reducing SDS-PAGE

<1 EU/μg, determined by LAL method.